非门脉高压性上消化道出血的临床特点及胃镜治疗效果探究

The Clinical Features of Non-portal Hypertension Upper Gastrointestinal Bleeding and the Effect of Gastroscope Treatment

目的探讨非门脉高压性上消化道出血的临床特点及胃镜治疗效果。方法方便选取新疆哈密市第二人民医院消化肿瘤内科2015年6月—2017年6月收治的90例非门脉高压性上消化道出血患者,以数字表法分组。对照组给予单一内科保守治疗,胃镜治疗组则给予内科保守联合胃镜治疗。比较两组非门脉高压性上消化道出血控制率;血压脉搏稳定时间、黑便消失时间、活动性出血消失时间、呕血消失时间;干预前后患者生活质量水平;再出血发生率。结果胃镜治疗组非门脉高压性上消化道出血控制率高于对照组(χ2=6.834,P<0.05)。对照组总有效率是68.89%;胃镜治疗组总有效率是95.56%。干预前两组生活质量水平相近,对照组是(64.13±10.23)分,胃镜治疗组是(64.11±10.22)分,(t=0.821,P>0.05);干预后胃镜治疗组生活质量水平(96.24±5.59)分优于对照组(80.24±4.94)分,(t=6.813,P<0.05)。胃镜治疗组血压脉搏稳定时间、黑便消失时间、活动性出血消失时间、呕血消失时间(16.12±1.41)、(23.13±0.24)、(11.13±0.24)、(10.13±0.24)h短于对照组(34.47±2.25)、(44.23±1.51)、(25.23±1.51)、(18.23±1.51)h,(t=7.223、6.023、8.011、9.063,P<0.05)。胃镜治疗组跟对照组比较,再出血发生率更低,对照组22.22%,胃镜治疗组6.67%(χ2=7.012,P<0.05)。结论非门脉高压性上消化道出血胃镜治疗效果确切,可有效改善临床症状,缩短止血疗程,缩短住院时间,改善患者生活质量,值得推广应用。

Objective This paper tries to explore the clinical features of non-portal hypertensive upper gastrointestinal bleeding and the therapeutic effect of gastroscopy. Methods Convenient select 90 with non-portal hypertension upper gastrointestinal bleeding were grouped by digital tables and included in the Department of Gastroenterology and Digestive Surgery of the Second People＇s Hospital of Hami City, Xinjiang from June 2015 to June 2017. The control group was given a single medical conservative treatment, gastroscopy treatment group was given conservative medical endoscopy treatment.Two groups of non-portal hypertension upper gastrointestinal bleeding control rate; blood pressure pulse stabilization time,the disappearance of black stools, active bleeding time, vomiting disappeared; patient quality of life before and after intervention; rebleeding incidence. Results The control rate of non-portal hypertension upper gastrointestinal bleeding was higher in the gastroscope group than in the control group（χ2=6.834, P〈0.05）. The total effective rate in the control group was68.89%; the total effective rate in the gastroscope group was 95.56%. Before the intervention, the quality of life of the two groups was similar, the control group was（64.13±10.23）points, the gastroscope treatment group was（64.11±10.22）points,（t=0.821, P〈0.05）; after the intervention gastroscopy treatment group, the quality of life level was（96.24±5.59）points was better than the control group of（80.24±4.94）points（t=6.813,P〈0.05）. In the gastroscope group, the time of blood pressure and pulse stabilization, the time of disappearance of black stools, the time of disappearance of active bleeding, and the time of disappearance of vomit blood were（16.12±1.41）,（23.13±0.24）,（11.13±0.24）,（10.13±0.24）h, which were shorter than the control group（34.47±2.25）,（44.23±1.51）,（25.23±1.51）,（18.23±1.51）h,（t=7.223, 6.023,8.011,9.063, P〈0.05）. Compared with the control group, the incidence of rebleeding was lower in the gastroscope treatment group, which was 22.22% in the control group and 6.67% in the gastroscope treatment group（χ2=7.012, P〈0.05）. Conclusion Non-portal hypertension upper gastrointestinal bleeding gastroscope treatment effect is accurate, can effectively improve the clinical symptoms, shorten the duration of hemostasis, shorten hospital stay, improve the quality of life of patients, it is worth promoting.